Kalamarides M - Search Results

1

Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.

Louvrier C, Pasmant E, Briand-Suleau A, Cohen J, Nitschké P, Nectoux J, Orhant L, Zordan C, Goizet C, Goutagny S, Lallemand D, Vidaud M, Vidaud D, Kalamarides M, Parfait B. Louvrier C, et al. Among authors: kalamarides m. Neuro Oncol. 2018 Jun 18;20(7):917-929. doi: 10.1093/neuonc/noy009. Neuro Oncol. 2018. PMID: 29409008 Free PMC article.

2

[Meningiomas].

Kalamarides M, Goutagny S. Kalamarides M, et al. Rev Prat. 2006 Oct 31;56(16):1792-8. Rev Prat. 2006. PMID: 17315505 Review. French.

3

[Neurofibromatosis type 2].

Goutagny S, Bouccara D, Bozorg-Grayeli A, Sterkers O, Kalamarides M. Goutagny S, et al. Among authors: kalamarides m. Rev Neurol (Paris). 2007 Sep;163(8-9):765-77. doi: 10.1016/s0035-3787(07)91459-9. Rev Neurol (Paris). 2007. PMID: 17878803 Review. French.

4

Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.

Lallemand D, Manent J, Couvelard A, Watilliaux A, Siena M, Chareyre F, Lampin A, Niwa-Kawakita M, Kalamarides M, Giovannini M. Lallemand D, et al. Among authors: kalamarides m. Oncogene. 2009 Feb 12;28(6):854-65. doi: 10.1038/onc.2008.427. Epub 2008 Nov 24. Oncogene. 2009. PMID: 19029950

5

Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status.

Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ, Black PM, Giovannini M, Carroll RS, Kalamarides M. Goutagny S, et al. Among authors: kalamarides m. Clin Cancer Res. 2010 Aug 15;16(16):4155-64. doi: 10.1158/1078-0432.CCR-10-0891. Epub 2010 Aug 3. Clin Cancer Res. 2010. PMID: 20682713

6

Meningiomas and neurofibromatosis.

Goutagny S, Kalamarides M. Goutagny S, et al. Among authors: kalamarides m. J Neurooncol. 2010 Sep;99(3):341-7. doi: 10.1007/s11060-010-0339-x. Epub 2010 Aug 17. J Neurooncol. 2010. PMID: 20714782 Review.

7

Meningioma mouse models.

Kalamarides M, Peyre M, Giovannini M. Kalamarides M, et al. J Neurooncol. 2010 Sep;99(3):325-31. doi: 10.1007/s11060-010-0331-5. Epub 2010 Aug 24. J Neurooncol. 2010. PMID: 20734219 Review.

8

Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab.

Goutagny S, Raymond E, Sterkers O, Colombani JM, Kalamarides M. Goutagny S, et al. Among authors: kalamarides m. Ann Oncol. 2011 Apr;22(4):990-991. doi: 10.1093/annonc/mdr012. Epub 2011 Feb 28. Ann Oncol. 2011. PMID: 21357650 Free article. No abstract available.

9

Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.

Peyre M, Goutagny S, Imbeaud S, Bozorg-Grayeli A, Felce M, Sterkers O, Kalamarides M. Peyre M, et al. Among authors: kalamarides m. Neuro Oncol. 2011 Oct;13(10):1125-32. doi: 10.1093/neuonc/nor101. Epub 2011 Jul 28. Neuro Oncol. 2011. PMID: 21798887 Free PMC article.

10

Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features.

Goutagny S, Bah AB, Henin D, Parfait B, Grayeli AB, Sterkers O, Kalamarides M. Goutagny S, et al. Among authors: kalamarides m. Neuro Oncol. 2012 Aug;14(8):1090-6. doi: 10.1093/neuonc/nos129. Epub 2012 Jun 18. Neuro Oncol. 2012. PMID: 22711605 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters